B-Cell immunity in the context of t-cell tolerance after combined kidney and bone marrow transplantation in humans

American Journal of Transplantation

Volumn 9, Issue 9, 2009, Pages 2126-2135

  Porcheray, F ^a   Wong, W ^b   Saidman, S L ^c   De Vito, J ^a   Girouard, T C ^c   Chittenden, M ^a   Shaffer, J ^a   Tolkoff Rubin, N ^b   Dey, B R ^d   Spitzer, T R ^d   Colvin, R B ^c   Cosimi, A B ^e   Kawai, T ^e   Sachs, D H ^a   Sykes, M ^a   Zorn, E ^a  

^a Transplantation Biology Research Center   (United States)

^b Renal Unit   (United Kingdom)

^c Department of Pathology ^*

^d Division of Bone Marrow Transplantation   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Antibodies; B cell; Tolerance induction

Indexed keywords

ALLOANTIBODY; IMMUNOGLOBULIN; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMORAL IMMUNITY; IMMUNOFLUORESCENCE TEST; KIDNEY TRANSPLANTATION; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; T LYMPHOCYTE;

B-LYMPHOCYTES; BONE MARROW TRANSPLANTATION; CELL LINE; COMPLEMENT C4B; ENZYME-LINKED IMMUNOSORBENT ASSAY; GRAFT REJECTION; HLA ANTIGENS; HUMANS; IMMUNE SYSTEM; IMMUNE TOLERANCE; KIDNEY TRANSPLANTATION; MICROSCOPY, FLUORESCENCE; PEPTIDE FRAGMENTS; PROTEIN ARRAY ANALYSIS; T-LYMPHOCYTES; TIME FACTORS;

EID: 69149102636     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02738.x     Document Type: Article

References (22)

1. Kawai T, Cosimi AB, Spitzer TR et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008 358 : 353 361.
2. Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC. Predominant autoantibody production by early human B cell precursors. Science 2003 301 : 1374 1377.
3. Marina O, Biernacki MA, Brusic V, Wu CJ. A concentration-dependent analysis method for high density protein microarrays. J Proteome Res 2008 7 : 2059 2068.
4. Cuss AK, Avery DT, Cannons JL et al. Expansion of functionally immature transitional B cells is associated with human-immunodeficient states characterized by impaired humoral immunity. J Immunol 2006 176 : 1506 1516.
5. Fang JC, Kinlay S, Behrendt D et al. Circulating autoantibodies to oxidized LDL correlate with impaired coronary endothelial function after cardiac transplantation. Arterioscler Thromb Vasc Biol 2002 22 : 2044 2048.
6. Wang SX, Ahola H, Palmen T, Solin ML, Luimula P, Holthofer H. Recurrence of nephrotic syndrome after transplantation in CNF is due to autoantibodies to nephrin. Exp Nephrol 2001 9 : 327 331.
7. Szewczyk M, Wielkoszynski T, Zakliczynski M, Zembala M, Szumska-Kostrzewska M. Anti-ox-LDL and anticardiolipin autoantibodies in patients after cardiac transplantation. Transplant Proc 2007 39 : 2870 2872.
8. Ducloux D, Bourrinet E, Motte G, Chalopin JM. Antiphospholipid antibodies as a risk factor for atherosclerotic events in renal transplant recipients. Kidney Int 2003 64 : 1065 1070.
9. Dragun D, Muller DN, Brasen JH et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 2005 352 : 558 569.
10. Shin YS, Yang CW, Ahn HJ et al. Clinical significance of anti-endothelial cell antibody in renal transplant recipients. Korean J Intern Med 2001 16 : 24 29.
11. Grimm PC, McKenna R, Nickerson P et al. Clinical rejection is distinguished from subclinical rejection by increased infiltration by a population of activated macrophages. J Am Soc Nephrol 1999 10 : 1582 1589.
12. Nagakawa Y, Nomoto S, Kato Y et al. Over-expression of AIF-1 in liver allografts and peripheral blood correlates with acute rejection after transplantation in rats. Am J Transplant 2004 4 : 1949 1957.
13. Mayo I, Arribas J, Villoslada P et al. The proteasome is a major autoantigen in multiple sclerosis. Brain 2002 125 (Pt 12 2658 2667.
14. Feist E, Brychcy M, Hausdorf G et al. Anti-proteasome autoantibodies contribute to anti-nuclear antibody patterns on human larynx carcinoma cells. Ann Rheum Dis 2007 66 : 5 11.
15. Beyer NH, Milthers J, Bonde Lauridsen AM, Houen G, Lautrup Frederiksen J. Autoantibodies to the proteasome in monosymptomatic optic neuritis may predict progression to multiple sclerosis. Scand J Clin Lab Invest 2007 67 : 696 706.
16. Stinton LM, Eystathioy T, Selak S, Chan EK, Fritzler MJ. Autoantibodies to protein transport and messenger RNA processing pathways: endosomes, lysosomes, Golgi complex, proteasomes, assemblyosomes, exosomes, and GW bodies. Clin Immunol 2004 110 : 30 44.
17. Ashton-Chess J, Giral M, Mengel M et al. Tribbles-1 as a novel biomarker of chronic antibody-mediated rejection. J Am Soc Nephrol 2008 19 : 1116 1127.
18. Lee PC, Terasaki PI, Takemoto SK et al. All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies. Transplantation 2002 74 : 1192 1194.
19. Tang AH, Platt JL. Accommodation of grafts: implications for health and disease. Hum Immunol 2007 68 : 645 651.
20. Sarantopoulos S, Stevenson KE, Kim HT et al. High levels of B-cell activating factor in patients with active chronic graft-versus-host disease. Clin Cancer Res 2007 13 : 6107 6114.
21. Sarantopoulos S, Stevenson KE, Kim HT et al. Altered B cell homeostasis and excess BAFF in human chronic graft versus host disease. Blood 2009 113 : 3865 3874.
22. Bernasconi NL, Traggiai E, Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002 298 : 2199 2202.